Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 147

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 147
---
 Please note that (i) our shares may not be offered or sold in Hong Kong, by means of this prospectus
or any document other than to “professional investors” within the meaning of Part I of Schedule 1 of the Securities and Futures
Ordinance (Cap.571, Laws of Hong Kong) (SFO) and any rules made thereunder, or in other circumstances which do not result in the document
being a “prospectus” within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong) (CO) or which do not constitute
an offer or invitation to the public for the purpose of the CO or the SFO, and (ii) no advertisement, invitation or document relating
to our shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere)
which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do
so under the securities laws of Hong Kong) other than with respect to the shares which are or are intended to be disposed of only to persons
outside Hong Kong or only to “professional investors” within the meaning of the SFO and any rules made thereunder.

| 88 |

<div align='center'>LEGAL MATTERS</div>

We are represented by Mintz,
Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Boston, Massachusetts, with respect to certain legal matters of U.S. federal securities
and New York law. The validity of our Ordinary Shares underlying the Depositary Shares and certain matters governed by English law will
be passed on for us by Stephenson Harwood LLP, London, United Kingdom. The placement agent is being represented by Thompson Hine
LLP, New York, New York.

<div align='center'>EXPERTS</div>

The financial statements as
of December 31, 2024, and for the year then ended, incorporated by reference into this prospectus and in the registration statement have
been so incorporated in reliance on a report PKF Littlejohn LLP, an independent registered accounting firm, given on authority of said
firm as experts in auditing and accounting. The report on the financial statements for the year ended December 31, 2024 contains an explanatory
paragraph regarding our ability to continue as a going concern.

PKF Littlejohn LLP, London,
United Kingdom, is a member of